BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30902141)

  • 1. Alzheimer's disease might depend on enabling pathogens which do not necessarily cross the blood-brain barrier.
    Block J
    Med Hypotheses; 2019 Apr; 125():129-136. PubMed ID: 30902141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to test antibacterial therapy in Alzheimer's disease.
    Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP
    Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Gut Microbiota and Alzheimer's Disease.
    Jiang C; Li G; Huang P; Liu Z; Zhao B
    J Alzheimers Dis; 2017; 58(1):1-15. PubMed ID: 28372330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal microbial dysbiosis aggravates the progression of Alzheimer's disease in Drosophila.
    Wu SC; Cao ZS; Chang KM; Juang JL
    Nat Commun; 2017 Jun; 8(1):24. PubMed ID: 28634323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Disease-a Critical Review.
    Sochocka M; Donskow-Łysoniewska K; Diniz BS; Kurpas D; Brzozowska E; Leszek J
    Mol Neurobiol; 2019 Mar; 56(3):1841-1851. PubMed ID: 29936690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective.
    Fox M; Knorr DA; Haptonstall KM
    Ann N Y Acad Sci; 2019 Aug; 1449(1):3-24. PubMed ID: 31180143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.
    Harris SA; Harris EA
    J Alzheimers Dis; 2015; 48(2):319-53. PubMed ID: 26401998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's Disease: From Amyloid to Autoimmune Hypothesis.
    Arshavsky YI
    Neuroscientist; 2020; 26(5-6):455-470. PubMed ID: 32111138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-Brain Barrier Integrity and Clearance of Amyloid-β from the BBB.
    Cockerill I; Oliver JA; Xu H; Fu BM; Zhu D
    Adv Exp Med Biol; 2018; 1097():261-278. PubMed ID: 30315550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of antimicrobial peptides in the early onset of Alzheimer's disease.
    Welling MM; Nabuurs RJ; van der Weerd L
    Alzheimers Dement; 2015 Jan; 11(1):51-7. PubMed ID: 24637300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The blood brain barrier in Alzheimer's disease.
    Chakraborty A; de Wit NM; van der Flier WM; de Vries HE
    Vascul Pharmacol; 2017 Feb; 89():12-18. PubMed ID: 27894893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Gut Microbiota in Health and Alzheimer's Disease.
    Szablewski L
    J Alzheimers Dis; 2018; 62(2):549-560. PubMed ID: 29480188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease and gut microbiota.
    Hu X; Wang T; Jin F
    Sci China Life Sci; 2016 Oct; 59(10):1006-1023. PubMed ID: 27566465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydia pneumoniae infection of monocytes in vitro stimulates innate and adaptive immune responses relevant to those in Alzheimer's disease.
    Lim C; Hammond CJ; Hingley ST; Balin BJ
    J Neuroinflammation; 2014 Dec; 11():217. PubMed ID: 25540075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota-gut-brain axis and Alzheimer's disease: Implications of the blood-brain barrier as an intervention target.
    Liu S; Gao J; Liu K; Zhang HL
    Mech Ageing Dev; 2021 Oct; 199():111560. PubMed ID: 34411603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Alzheimer's disease a polymicrobial host microbiome dysbiosis?
    Singhrao SK; Harding A
    Expert Rev Anti Infect Ther; 2020 Apr; 18(4):275-277. PubMed ID: 32048530
    [No Abstract]   [Full Text] [Related]  

  • 18. Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and abeta fibril disaggregation.
    Boado RJ; Zhang Y; Zhang Y; Xia CF; Pardridge WM
    Bioconjug Chem; 2007; 18(2):447-55. PubMed ID: 17315944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of in vitro cultured endothelial progenitor cells repairs the blood-brain barrier and improves cognitive function of APP/PS1 transgenic AD mice.
    Zhang S; Zhi Y; Li F; Huang S; Gao H; Han Z; Ge X; Li D; Chen F; Kong X; Lei P
    J Neurol Sci; 2018 Apr; 387():6-15. PubMed ID: 29571873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of evidence for or against contributions of Chlamydia pneumoniae infections to Alzheimer's disease etiology.
    Woods JJ; Skelding KA; Martin KL; Aryal R; Sontag E; Johnstone DM; Horvat JC; Hansbro PM; Milward EA
    Brain Behav Immun; 2020 Jan; 83():22-32. PubMed ID: 31626972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.